ENTITY
Cellivery Therapeutics

Cellivery Therapeutics (268600 KS)

3
Analysis
Health CareSouth Korea
Cellivery Therapeutics, Inc. operates as a pharmaceutical company. The Company develops and sells proteins drugs and other products, as well as conducts research and development activities. Cellivery Therapeutics markets its products throughout Korea.
more
bullishWYSIWYG Studios
09 Nov 2023 03:27

Momentum Trading Opportunities Among Top 50 Stocks in KOSDAQ With Highest Short Interest Ratios

In this insight, we discuss near-term momentum trading opportunities among the top 50 stocks in KOSDAQ with highest short interest ratios.

Logo
396 Views
Share
26 Mar 2023 06:26

KOSDAQ150 Ad Hoc Index Rebalance: Humasis (205470 KS) To Replace Cellivery (268600 KS)

Humasis replaces Cellivery in the KOSDAQ150 Index - the timing of the change is currently uncertain. Humasis was a potential add in June - the...

Logo
547 Views
Share
No more insights
x